Breast Cancer
Molecular interaction found to trigger particularly aggressive form of disease
Published in Gene Therapy Weekly, February 9th, 2006
In the January 2006 issue of Cancer Cell, a team led by Qunyan Yu, MD, and Piotr Sicinski, MD, PhD, of the Dana-Farber Cancer Institute, report that the interaction of a certain mutated oncogene and the newly described growth control flaw is seen in about 10% of breast cancers - and the deadliest ones (Requirement for CDK4 kinase function in breast cancer. Cancer Cell, January 2006;9(1):23-32).
The cancer results from a cascade of molecular events....
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Gene Therapy Weekly
Source: Gene Therapy Weekly (2006-02-09)
More Articles from Gene Therapy Weekly
- Antisense Technology
Antisense knockdown of cyclin E does not affect the midblastula transition - Gene Therapy
Adenovirus genome insertion sites utilize splicing machinery for therapeutic gene expression - Gene Therapy
Erythropoietin gene transfer reduces risk of germ cell loss caused by cryptorchidism - Gene Therapy
Norepinephrine transporter contributes to PET of gene therapy - Gene Therapy
Sea urchin sns chromatin insulator characterized in erythroid cells - Acute Respiratory Distress Syndrome
Study reveals new player in sepsis-associated condition - More from this issue of Gene Therapy Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
